Frank H. Laukien, President and CEO of Bruker Corp (NASDAQ:BRKR), filed a Form 4 on August 13, 2026, disclosing a transaction in Bruker common stock dated August 11, 2026.

Key Highlights

  • Transaction type: 4,838 shares of Bruker common stock were disposed of under transaction code "F" at a price of $57.02 per share.
  • Purpose: According to the filing, the shares were "withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the reporting person."
  • Direct holdings after transaction: Laukien beneficially owned 38,482,340 shares directly following the reported transaction.
  • Indirect holdings: The filing reports additional indirect beneficial ownership across multiple parties, including 1,055,639 shares held by a former spouse, 337,087 shares by a son, and 336,607 shares by a daughter, among other positions.
  • Roles: The filing identifies Laukien as a Director, a 10% Owner, and an Officer with the title President and CEO.

Bruker CEO Discloses Share Withholding Tied to RSU Vesting

According to the Form 4 filed with the SEC on August 13, 2026, Frank H. Laukien, President and CEO of Bruker Corp, reported a disposition of 4,838 shares of Bruker common stock on August 11, 2026. The transaction carried code "F," and the filing states the shares represent amounts withheld by the company to cover tax obligations arising from the vesting of previously granted restricted stock units. The per-share price recorded in the filing is $57.02.

Following the reported transaction, the filing shows Laukien directly holds 38,482,340 shares of Bruker common stock. The filing also lists several indirect ownership positions: 1,055,639 shares held by a former spouse, 337,087 shares held by a son, 336,607 shares held by a daughter, 201,702 shares held as UTMA Custodian for a son, 71,728 shares held as UTMA Custodian for a son, 1,043 shares held by a former spouse, and 272 shares held by a son.

No derivative securities transactions were reported in Table II of the filing. The Form 4 was signed by Betsy Eberg as Attorney-in-Fact on August 13, 2026, and was filed by one reporting person.

What Was Disclosed

Laukien's Form 4 disclosed the withholding of 4,838 shares at $57.02 per share by Bruker Corp to satisfy tax obligations connected to RSU vesting, leaving him with 38,482,340 directly held shares as of August 11, 2026.